Exploring the Role of Presepsin in the Prediction of Atrial Fibrillation Recurrence: Results from the PLACEBO Study
In this exploratory study, OSA emerged as the only independent predictor of AF recurrence. Presepsin was not significantly associated with recurrence in the present cohort; however, given the limited sample size and exploratory design, these results do not exclude a potential association. Larger, adequately powered studies are needed to clarify the role of presepsin in AF recurrence risk.
Authors
- Theocharis Koufakis (ORCID: https://orcid.org/0000-0002-5853-1352)
- Aikaterini Balaska
- Aristi Boulmpou (ORCID: https://orcid.org/0000-0002-5008-114X)
- Georgios Dimakopoulos (ORCID: https://orcid.org/0000-0002-2351-7411)
- Christodoulos E. Papadopoulos (ORCID: https://orcid.org/0000-0001-9643-9066)
- Michael Doumas (ORCID: https://orcid.org/0000-0002-7269-8044)
- Vassilios Pericles Vassilikos (ORCID: https://orcid.org/0000-0003-0885-9170)
- Kalliopi Kotsa (ORCID: https://orcid.org/0000-0003-2376-740X)
- Georgios Zormpas (ORCID: https://orcid.org/0009-0004-2370-2811)
- Dimitrios Kouroupis (ORCID: https://orcid.org/0009-0005-7732-709X)
Institutions
- University of Ioannina (GR)
- Aristotle University of Thessaloniki (GR)
- AHEPA University Hospital (GR)
- Ippokrateio General Hospital of Thessaloniki (GR)
Publication Details
- Journal
- Diseases
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3390/diseases13100349
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00